BGMS BIO GREEN MED SOLUTION INC revenue, earnings and financials

For the quarter ended June 30, 2026, BIO GREEN MED SOLUTION INC reported revenue of $336K, net income of −$405K and diluted EPS of n/a; for the fiscal year ended December 2025 revenue was $0, down 100.0% on the year before.

BGMS annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income −$8.43M, net income −$3.00M (margin n/a), EPS −$6.45
• Fiscal year ended Dec 2024: revenue $43.0K, gross profit n/a, operating income −$12.0M, net income −$11.2M (margin -26074.4%), EPS −$502.46
• Fiscal year ended Dec 2023: revenue $420K, gross profit n/a, operating income −$25.5M, net income $22.6M (margin 5370.2%), EPS −$6419.18
• Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$27.7M, net income −$21.2M (margin n/a), EPS −$27.24
• Fiscal year ended Dec 2021: revenue $0, gross profit n/a, operating income −$22.4M, net income −$18.5M (margin n/a), EPS −$2.09

BGMS quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $336K, net income −$405K, EPS n/a
• Quarter ended Mar 31, 2026: revenue $743K, net income −$197K, EPS n/a
• Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$611K, EPS −$4.16
• Quarter ended Sep 30, 2025: revenue $81.0K (up 710.0% year over year), net income −$988K, EPS −$1.31
• Quarter ended Jun 30, 2025: revenue n/a, net income −$1.32M, EPS −$0.98
• Quarter ended Mar 31, 2025: revenue n/a, net income −$81.0K, EPS $0.00
• Quarter ended Dec 31, 2024 (from the annual report): revenue $0 (down 100.0% year over year), net income −$3.05M, EPS −$284.21
• Quarter ended Sep 30, 2024: revenue $10.0K (down 37.5% year over year), net income −$1.96M, EPS −$43.80
• Quarter ended Jun 30, 2024: revenue $4.00K (down 98.9% year over year), net income −$3.26M, EPS −$172.18
• Quarter ended Mar 31, 2024: revenue $29.0K, net income −$2.95M, EPS −$2.27
• Quarter ended Dec 31, 2023 (from the annual report): revenue $31.0K, net income $39.8M, EPS n/a
• Quarter ended Sep 30, 2023: revenue $16.0K, net income −$6.03M, EPS n/a
• Quarter ended Jun 30, 2023: revenue $373K, net income −$5.45M, EPS −$0.44
• Quarter ended Mar 31, 2023: revenue $0, net income −$5.80M, EPS −$7.00
• Quarter ended Dec 31, 2022 (from the annual report): revenue $0, net income −$7.42M, EPS −$25.94
• Quarter ended Sep 30, 2022: revenue $0, net income −$5.10M, EPS −$0.42
• Quarter ended Jun 30, 2022: revenue $0, net income −$4.58M, EPS −$0.46
• Quarter ended Mar 31, 2022: revenue $0, net income −$4.11M, EPS −$0.42
• Quarter ended Dec 31, 2021 (from the annual report): revenue $0, net income −$5.10M, EPS −$0.52
• Quarter ended Sep 30, 2021: revenue $0, net income −$4.76M, EPS −$0.51

BGMS cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$4.77M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$7.99M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$16.1M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$20.8M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$18.5M, share buybacks n/a

BGMS balance sheet

• Jun 30, 2026: cash $3.79M, total assets $7.85M, total liabilities $694K, shareholders' equity $7.16M
• Mar 31, 2026: cash $3.34M, total assets $7.56M, total liabilities $804K, shareholders' equity $6.76M
• Dec 31, 2025: cash $3.51M, total assets $8.19M, total liabilities $1.34M, shareholders' equity $6.84M
• Sep 30, 2025: cash $3.84M, total assets $8.16M, total liabilities $1.06M, shareholders' equity $7.10M
• Jun 30, 2025: cash $4.28M, total assets $4.40M, total liabilities $770K, shareholders' equity $3.63M
• Mar 31, 2025: cash $3.45M, total assets $3.73M, total liabilities $672K, shareholders' equity $3.06M
• Dec 31, 2024: cash $3.14M, total assets $4.09M, total liabilities $6.27M, shareholders' equity −$2.17M
• Sep 30, 2024: cash $2.98M, total assets $5.38M, total liabilities $6.35M, shareholders' equity −$970K

What is BGMS's revenue?

BIO GREEN MED SOLUTION INC reported $0 of revenue for the fiscal year ended December 2025.

Is BGMS profitable?

No. BIO GREEN MED SOLUTION INC lost $2.20M over the last four quarters.

BGMS ownership and insider trades · All stocks